Insufficiency fractures in rheumatology. Case report and overview;Insuffizienzfrakturen in der rheumatologie. Fallbeschreibung und übersicht

Zeitschrift fur Rheumatologie

Volumn 65, Issue 5, 2006, Pages 417-423

  Dreher, R ^a,f   Buttgereit, F ^a,b   Demary, W ^a   Gortz B ^c   Hein, G ^a,d   Kern, P ^a,e   Schulz, A ^c  

^a Kommission Osteologie DGRh ^*  (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

^e Franz von Prummer Klinik   (Germany)

^f Rheumakrankenhaus   (Germany)

Author keywords

Glucocorticoids; Insufficiency fractures; Renal osteodystrophy; Rheumatoid arthritis; Stress fractures

Indexed keywords

ALFACALCIDOL; ALKALINE PHOSPHATASE; AMLODIPINE; CALCIUM; DALTEPARIN; FLUORIDE; FUROSEMIDE; GLUCOCORTICOID; OMEPRAZOLE; PARATHYROID HORMONE; PHOSPHATE; PREDNISOLONE; TRAMADOL;

ADULT; AGE DISTRIBUTION; ANAMNESIS; ARTICLE; BODY MASS; BONE BIOPSY; BONE DENSITOMETRY; BONE SCINTISCANNING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBULA; FIBULA FRACTURE; HIP FRACTURE; HUMAN; HYPERPARATHYROIDISM; IMMOBILIZATION; KIDNEY FAILURE; LUMBAR VERTEBRA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMALACIA; RENAL OSTEODYSTROPHY; RHEUMATOID ARTHRITIS; RISK FACTOR; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; STRESS FRACTURE; TIBIA; TIBIA FRACTURE; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION; X RAY;

AGED; ARTHRITIS, RHEUMATOID; BIOPSY; BONE AND BONES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBULA; FRACTURES, SPONTANEOUS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; IMMUNOSUPPRESSIVE AGENTS; LONG-TERM CARE; OSTEOMALACIA; PREDNISOLONE; RENAL OSTEODYSTROPHY; TIBIAL FRACTURES;

EID: 33749117173     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-006-0089-5     Document Type: Article

References (47)

1. Alem AM, Sherrad DJ, Gillen DL et al. (2000) Increased risk of hip fractures among patients with end-stage renal disease. Kidney Int 58: 396-399
2. Bouquillard E, Marcelli C, Herisson C, Simon L (1991) Les fractures par insuffisance osseuse du bassin el des membres inferieurs; role favorisant du fluor. A propos de soixante-quatre observations. Sem Hop Paris 76: 1755-1761
3. Canalis E (1996) Mechanism of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81: 3441-3447
4. Carter DR, Beaupre GS (1990) Effects of fluoride treatment on bone strength. J Bone Min Res 5 (Suppl): 177-184
5. Chapuy MC, Pamphile R, Paris E et al. (2002) Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporosis Int 13: 257-264
6. Cooper C, Coupland C, Mitchell M (1995) Rheumatoid arthrtis, corticosteroid therapy and hip fracture. Ann Rheum Dis 54: 49-52
7. Delany A, Gabbitas B, Canalis E (1995) Cortisol down-regulates osteoblast alpha 1(I) procollagen in RNA by transcriptional and posttranscriptional mechanisms. J Cell Biochem 57: 488-494
8. Dreher R, Sommer G, Emrich G (1999) Low-dose glukokortikoid- ssoziierte Osteoporose und Knochenstoffwechsel unter besonderer Berücksichtigung des Parathormons. Osteologie 8: (Suppl 1): 64 (abstract)
9. Dreher R, Lingg G, Zink A, Listing J (2001) Risk of osteoporosis in rheumatological diseases. Bone 28 (suppl 5): 195 (abstract)
10. Dreher R, Lingg G, Zöller A, Eckhardt A (2003) Effective off-label Therapie mit Infliximab bei rheumatoider Arthritis mit generalisierten Ermüdungsfrakturen. Osteologie 12 (Suppl 1): (abstract)
11. Elkayam O, Paran D, Flusser G et al. (2000) Insufficiency fractures in rheumatic patients: misdiagnosis and underlying characteristics. Clin Exp Rheumatol 18: 369-374
12. Finiels H, Finiels PJ, Jaquot JM, Strubel D (1997) Fractures du sacrum par insuffisance osseuse. Meta -analyse de 508 cas. Presse Med 26: 1568-1573
13. Franco M, Bendini JC, Blaimont A et al. (2003) Longitudinal bone insufficiency fracture of the tibia in a renal transplant recipient. Joint Bone Spine 70: 296-299
14. Gerakis A, Hadjidakis D, Kokkinakis E et al. (2000) Correlation of bone mineral density with the histological finding renal dystrophy in patients on hemodialysis. J Nephrol 13: 437-443
15. Haguenauer D, Welch V, Shea B et al. (2000) Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis. Osteoporosis Int 11: 272-238
16. Haugeberg G, Uhlig T, Falch JA et al. (2000) Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: Results from 394 patients in the Oslo country rheumatoid arthritis register. Arthritis Rheum 43: 522-530
17. Hedlund LR, Gallagher JC (1989) Increased incidience of hip fracture in osteoporotic women treated with sodium fluoride. J Bone Miner Res 4: 223-225
18. Ho LT, Sprague SM (2002) Percutaneous bone biopsy in the diagnosis of renal osteodystrophy. Semin Nephrol 22: 268-275
19. Hooyman JR, Melton J III J, Nelson AM et al. (1984) Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum 27: 1353-1361
20. Hoshino Y, Doita M, Yoshikawa M et al. (2004) Unstable pelvic insufficiency fracture in a patient with rheumatoid arthritis. Rheumatol Int 24: 46-49
21. Kageyama Y, Nagafusa I, Nagano A (2005) Insufficiency fracture of the tarsal navicular in a patient with rheumatoid arthritis. Rheumatology (Oxford) 44: 949-950
22. Kanis JA, Johannsen H, Oden A et al. (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19: 893-899
23. Laan RFJM, van Riel PLCM, van de Putte LBA et al. (1993) Low-dose prednisolone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Int Med 119: 963-968
24. Leitlinien des Dachverbandes Osteologie zur Osteoporose (2006) (im Druck)
25. Lips P (2001) Vitamin D defiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic complications. Endocrin Rev 22: 477-501
26. Lukert BP, Raisz LG (1990) Glucocorticoid- induced osteoporosis: pathogenesis and management. Ann Intern Med 112: 352-364
27. Mäenpää HM, Soini I, Lehto MUK, Belt EA (2002) Insufficiency fractures in patients with chronic inflammatory joint diseases. Clin Exp Rheumatol 20: 77-79
28. Negri AL, Lombas C, Cuevas C et al. (2005) Evaluation of cortical bone by peripheral quantitaive computed tomography in renal transplant recipients. Transplant Proc 37: 1020-1022
29. Noble BS, Stevens H, Loveridge N et al. (1997) Identification of apototic changes in osteocytes in normal and pathological human bone. Bone 20: 273-282
30. Oelzner P, Müller A, Deschner F et al. (1997) Knochenstoffwechsel bei rheumatoider Arthritis: vergleichende Untersuchung des Einflusses von Entzündungsaktivität und Glukokortikoidtherapie. Z Rheumatol 56 (Suppl 1): 23 (abstract)
31. Ostravik RE, Haugeberg G, Uhlig T et al. (2004) Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables. Ann Rheum Dis 63: 177-182
32. Ozaki D, Shira Y, Nakayama Y, Uesaka S (2000) A case report of insufficiency fracture of the fossa acetabuli in a patient with rheumatoid arthritis. J Nippon Med Sch 67: 267-270
33. Peel NFA (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54: 801-806
34. Peretz A, Praet JP, Bosson D et al. (1989) Serum osteocalcin in the assessment of corticosteroid induced osteoporosis. Effect of long and short term corticoid treatment. J Rheumatol 16: 363-367
35. Raspe H, Dreher R, Zeidler H, Zink A (BMFT geförderte Studie, noch nicht publiziert) Osteoporose bei Patienten mit rheumatoider Arthritis (RA): Prävalenz, Risikofaktoren, Versorgungsprobleme
36. Riggs BL, Hodgson SF, Hoffmann DL, Johnson KA (1980) Treatment of primary osteoporosis with fluoride and calcium. J Am Med Assoc 243: 466-469
37. Rubin MR, Bilezikian JP (2002) The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a reexamination of the evidence. J Clin Endocrinol Metab 87: 4033-4041 (abstract)
38. Saag KG, Koehnke R, Caldwell JR et al. (1994) Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Ann J Med 96: 115-123
39. Sahota O, Gaynor K, Harwood RH, Hosking DJ (2001) Hypovitaminosis D and "functional hypoparathyroidism" - the No No F (Nottingham Neck of Femur) study. Age Ageing 30: 467-472
40. Santos FRL, Moyses RMA, Montenegro FLM et al. (2003) IL-1, TNF-alpha, TGFand bFGF expression in bone biopsies before and after parathyroidectomy. Kidney Int 63: 899-907
41. Shenstone BD, Mahmoud R, Woodward R et al. (1994) Longitudinal bone mineral density changes in early rheumatoid arthritis. Br J Rheumatol 33: 541-545
42. Soubrier M, Dubost JJ, Boisgard S et al. (2003) Insufficiency fracture. A survey of 60 cases and review of the literature. Joint Bone Spine 70: 209-218
43. Van Staa TP, Leufkens HGM, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporosis Int 13: 777-787
44. Varghese S, Ramsby ML, Jefferey JJ, Canalis E (1995) Basic fibroblast growth factor stimulates expression of interstitial collagenase and inhibitors of metalloproteinases in rat bone calls. Endocrinology 136: 2156-2162
45. Verstraeten A, Dequeker J, Nijs J, Geusens P (1989) Prevention of postmeonpausal bone loss in rheumatoid arthritis patients. A two-year prospective study. Clin Exp Rheumatol 7: 541-545
46. Vestergaard P, Olsen ML, Paaske Johnson S et al. (2003) Corticosteroid use and risk of hip fracture: a population-based case-control study in Denmark. J Intern Med 254: 486-493
47. Weinstein RS, Jilka RL, Parf AM II, Manolagas C (1998) Inhibition of osteoblastogenesis and promotion of apotosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102: 274-282